These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 3945450)

  • 21. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 24. [Spontaneous regression of serum HCG in 18 patients following evacuation of uncomplicated androgenic moles].
    Vejerslev LO; Arends J; Larsen SO
    Ugeskr Laeger; 1988 Aug; 150(35):2081-3. PubMed ID: 3413897
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK; Gokel JM; Holzmann K
    Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
    Dawood MY; Brown JB; Newnam KL
    Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating inhibin forms in patients with hydatidiform mole.
    Kato T; Seki K; Matsui H; Sekiya S
    Gynecol Obstet Invest; 2002; 54(2):114-7. PubMed ID: 12566755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin: a new circulating marker of hydatidiform mole?
    Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
    BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
    J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone.
    Soules MR; Hughes CL; Garcia JA; Livengood CH; Prystowsky MR; Alexander E
    Obstet Gynecol; 1980 Jun; 55(6):696-700. PubMed ID: 7383455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum TSH levels in normal pregnant women and patients with hydatidiform mole and influence of HCG on TSH immunoradiometric assay].
    Hara H; Ban Y; Sato R; Nagakura H; Kushima K; Kaihara M; Matsuzaki H
    Kaku Igaku; 1988 Jan; 25(1):89-96. PubMed ID: 3373811
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
    Lim YC; Chew SC; Ratnam SS
    Acta Obstet Gynecol Scand; 1976; 55(5):407-12. PubMed ID: 187001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
    Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
    Ngowngarmratana S; Sunthornthepvarakul T; Kanchanawat S
    J Med Assoc Thai; 1997 Nov; 80(11):693-9. PubMed ID: 9385765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.